Endogenous carriers and ligands in non-immunogenic site-specific drug delivery

SP Vyas, V Sihorkar - Advanced drug delivery reviews, 2000 - Elsevier
Targeted drug delivery has gained recognition in modern therapeutics and attempts are
being made to explore the potentials and possibilities of cell biology related bioevents in the …

Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin …

JE Nagel, RK Chopra, FJ Chrest… - The Journal of …, 1988 - Am Soc Clin Investig
Using cDNA probes to human interleukin 2 (IL2) and interleukin 2 receptor (IL2R), the
amount of IL2 and IL2R mRNA produced by PHA stimulated peripheral blood mononuclear …

Serum interleukin‐15 is elevated in systemic lupus erythematosus

M Aringer, GH Stummvoll, G Steiner, M Köller… - …, 2001 - academic.oup.com
Objective. To investigate if interleukin‐15 (IL‐15)(rather than IL‐2) is increased in systemic
lupus erythematosus (SLE) and might be responsible for immunological abnormalities of …

Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein

X Xu, P Clarke, G Szalai, JE Shively, LE Williams… - Cancer Research, 2000 - AACR
The purpose of this study was to engineer a bivalent single-chain anticarcinoembryonic
antigen (CEA) antibody and an interleukin 2 (IL-2) fusion protein derivative for selective …

[HTML][HTML] Biological role of the soluble interleukin-2 receptor in sarcoidosis

RMM Vanmaris, GT Rijkers - Sarcoidosis, Vasculitis, and Diffuse …, 2017 - ncbi.nlm.nih.gov
Sarcoidosis is a systemic inflammatory disease characterized by granulomatous
inflammation. The soluble interleukin-2 receptor (sIL-2R) is used as a biomarker for disease …

SERUM CYTOKINE LEVELS AFTER HLA-IDENTICAL BONE MARROW TRANSPLANTATION1

LM Liem, HC van Houwelingen, E Goulmy - Transplantation, 1998 - journals.lww.com
Background. Altered profiles of cytokine production are observed after bone marrow
transplantation (BMT). The presence of certain cytokines in serum can be indicative for BMT …

Soluble interleukin-2 receptor serum levels after allogeneic bone marrow transplantation as a marker for GVHD

J Grimm, W Zeller, AR Zander - Bone marrow transplantation, 1998 - nature.com
Acute GVHD (aGVHD) is one of the major problems after allogeneic BMT. The diagnosis of
aGVHD is difficult to establish, relying mainly on clinical evaluations and symptoms of …

Soluble interleukin‐2 receptor, interleukin‐2 and interleukin‐4 in sera and supernatants from patients with progressive systemic sclerosis

G Famularo, A Procopio, R Giacomelli… - Clinical & …, 1990 - Wiley Online Library
We studied the sera of patients with progressive systemic sclerosis (PSS) for elevated levels
of soluble interleukin‐2 receptor (sIL‐2R), interleukin‐2 (IL‐2) and interleukin‐4 (IL‐4). We …

Concentrations of cytokines, soluble interleukin-2 receptor, and soluble CD30 in sera of patients with hepatitis B virus infection during acute and convalescent phases

F Monsalve-de Castillo, TA Romero… - Clinical and Vaccine …, 2002 - Am Soc Microbiol
The immunoregulatory roles of interleukin-2 (IL-2), IL-4, IL-10, gamma interferon (IFN-γ),
tumor necrosis factor alpha (TNF-α), the soluble form of the IL-2 receptor (sIL-2R), and the …

Evaluation of serum levels of solubilized adhesion molecules and cytokine receptors in coronary heart disease

M Porsch-Oezçueruemez, D Kunz, HU Kloer… - Journal of the American …, 1999 - jacc.org
OBJECTIVES The diagnostic importance of circulating solubilized tumor necrosis factor-
alpha receptor II (sTNF-αRII) and interleukin-2 receptor in coronary heart disease (CHD) …